Shuqun D. Cheng
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 85 publications
From HCC Risk Prediction to Surveillance Exemption in Older Adults With MASLD.
Journal: Journal of gastroenterology and hepatology
Published: August 07, 2026
Therapy of allergic rhinitis using ribavirin spray to clear nasal commensal viruses.
Journal: Signal transduction and targeted therapy
Published: November 24, 2025
Low-dose chemotherapy remodels hepatic immune landscape and potentiates anti-tumor response to immune checkpoint blockade in cholangiocarcinoma.
Journal: Hepatology (Baltimore, Md.)
Published: November 01, 2025
Radiation-induced CD200+ tumor-associated macrophages suppress eosinophil-mediated antitumor immunity through CD200R signaling in hepatocellular carcinoma.
Journal: Cellular & molecular immunology
Published: October 29, 2025
Enhanced efficacy and long-term survival with SBRT plus PD-1 inhibitors versus SBRT alone in unresectable HCC: a multicenter PSM study.
Journal: The oncologist
Published: October 22, 2025
Enhancing the clinical utility of a ten-gene prognostic signature for HCC.
Journal: Annals of hepatology
Published: August 18, 2025
Comment on "Sarcopenia and myosteatosis are associated with low survival in patients receiving lenvatinib for unresectable hepatocellular carcinoma".
Journal: Journal of the Formosan Medical Association = Taiwan yi zhi
Published: July 29, 2025
Real-world outcomes of stereotactic body radiotherapy plus sintilimab and bevacizumab for hepatocellular carcinoma with portal vein tumor thrombus.
Journal: The oncologist
Published: May 21, 2025
The noncanonical function of liver-type phosphofructokinase potentiates the efficacy of HDAC inhibitors in cancer.
Journal: Signal transduction and targeted therapy
Published: March 29, 2025
Comment on "Is liver resection still required for patients who have predictive factors for complete pathologic necrosis after downstaging treatments of locally advanced hepatocellular carcinoma?"
Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
Published: March 23, 2025
Ultrasounic-radiomics models for predicting the response to Atezolizumab plus Bevacizumab in patients with unresectable hepatocellular carcinoma.
Journal: PloS one
Published: March 11, 2025
Chinese expert consensus on conversion and perioperative therapy of primary liver cancer (2024 edition).
Journal: Hepatobiliary surgery and nutrition
Published: February 28, 2025
Last Updated: 09/26/2026